VanEck Vectors Pharmaceutical ETF (PPH)

63.64
Delayed Data
As of 3:59pm ET
 +0.05 / +0.08%
Today’s Change
54.44
Today|||52-Week Range
64.65
+7.30%
Year-to-Date

Investment Objective

The investment seeks to replicate as closely as possible- before fees and expenses- the price and yield performance of the MVIS- US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for VanEck Vectors Pharmaceutical ETF.

Performance

1 month+0.41% 3 years-0.42%
3 months+6.52% 5 years+7.57%
1 year+13.07% Since inception+11.19%
Data through 09/19/2018

Quote Details

Previous close$63.59
Open day’s range63.52 – 63.93
Net asset value (NAV)63.62 (09/18/2018)
Daily volume28,738
Average volume (3 months)32,300
Data as of 3:59pm ET, 09/19/2018

Peer Comparisonvs. Health ETFs

 PPHCategory
Performance 5-yr return+7.57%+14.50%
Expense Gross exp ratio0.40%1.30%
Risk 5 year sharpe ratio0.641.00
Net assets$288.7M$3.5B
Average market cap$48.5B$30.1B
Average P/E21.428.7
Dividend / Share--0.31%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
BMY Bristol-Myers Squibb5.37%
PFE Pfizer5.36%
SNY Sanofi5.20%
MRK Merck5.20%
LLY Eli Lilly and Co5.20%
NVS Novartis5.18%
JNJ Johnson & Johnson5.15%
NVO Novo Nordisk4.93%
AZN AstraZeneca4.92%
GSK GlaxoSmithKline4.68%